Navigation Links
Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
Date:11/2/2009

COPENHAGEN, November 2 /PRNewswire/ -- Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.

The payment was triggered following identification of several candidate molecules that conformed to the prespecified criteria established under the terms of the original agreement. These include several accepted drug-like characteristics and nanomolar potency.

In its collaboration with Merck, Nuevolution is applying its proprietary Chemetics(R) technology to identify novel small molecule leads against drug targets of interest to Merck. Nuevolution has so far screened more than one billion small molecules against the first of the targets selected under the collaboration. The candidate molecules so far identified have been shown to disrupt an undisclosed, therapeutically relevant, protein-protein interaction in vitro.

"We are excited about the results that have been obtained thus far in the collaboration with Merck. Considering the complexity of the target, we believe that the results demonstrate the value of having access to hundreds of millions to billions of small molecules for screening," said Alex Gouliaev, CEO of Nuevolution A/S. "It is a great pleasure working with Merck's first class team of scientists, and we are looking forward to a continued fruitful outcome of the collaboration."

Merck and Nuevolution entered into a collaboration in 2008. In April 2009, Nuevolution announced an expansion to the second phase of the collaboration.

About Nuevolution

Nuevolution is a leading small molecule lead discovery company founded in 2001 and based in Copenhagen, Denmark. The company has developed Chemetics(R), a unique, patent protected hybrid of proven wet chemistry and molecular biology which represents the ultimate fragment based drug discovery technology. Chemetics(R)
'/>"/>

SOURCE Nuevolution A/S
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... February 9 Debiopharm Group,(Debiopharm), ... with,a focus on the development of prescription ... the signature of an exclusive licence agreement ... of Debio 025,(alisporivir), a selective, first-in-class cyclophilin ... (HCV) effect. The product is currently in ...
(Date:2/8/2010)... Ore. , Feb. 8 ... to a steady increase in the use and ... such as arthritis and psoriasis. This has led ... overall drug costs and medication coverage being spread ... introduced a new solution with Medication Cost Integration ...
(Date:2/8/2010)... A.W.A.R.E., Initiative Drives Awareness for Improving the Safety ... FLORHAM PARK, N.J. , Feb. 8 ... launch of a new initiative to promote safer ... hospitals based on the American Society for Parenteral ... ,, The "Be A.W.A.R.E." campaign is designed to ...
Breaking Medicine Technology:Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3RegenceRx Leads the Industry With Introduction of Medication Cost Integration 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 3Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 2Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 3Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 4Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 5DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 1DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 2Unspoken memories of Holocaust survivors find silent and nonpathological expression 49625 1Unspoken memories of Holocaust survivors find silent and nonpathological expression 49625 2Toxic molecule may help birds see north and south 8951 1Toxic molecule may help birds see north and south 8951 2
... is pleased to announce its involvement in a five-year clinical ... TH,s collaborator, Duke University , was the recipient of ... by the foundation in 2009 to further the development of ... Komen for the Cure(R) is a nonprofit organization dedicated to ...
... New Health Sciences Inc. (NHSi) has won ... Heart, Lung and Blood Institute of the National Institutes ... The project aims to develop the Hemanext Anaerobic ... therapy and extends the shelf life of blood for ...
Other Medicine Technology:Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 2Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 3Bethesda-Based NHSi Wins $2M Grant for Blood Technology 2Bethesda-Based NHSi Wins $2M Grant for Blood Technology 3
(Date:2/9/2010)... the Ireland Cancer Center of University Hospitals (UH) Case ... to a new standard of care for patients with ... February issue of Clinical Cancer Research, the ... Triapine, was well tolerated in combination with standard-of-care cisplatin ... This regimen provided both significant reduction in cancer disease ...
(Date:2/9/2010)... Problem-Riddled Health Freedom Act Could See Idaho Lose $1.6 ... BOISE, Idaho , Feb. 9 ... to oppose a non-existent federal health care law, the long-term ... come.  AARP is calling the Idaho Health Freedom Act (House ... if signed into law, could see Idaho lose ...
(Date:2/9/2010)... The most comprehensive study to date of secondhand smoke ... the journal Addiction . The study, carried out ... Health, reveals that exposure to household secondhand smoke among ... The researchers wanted to find out if there were ... by children in private households, and whether those levels ...
(Date:2/9/2010)... Consuming two or more soft drinks per week increased ... compared with individuals who did not consume soft drinks, ... & Prevention , a journal of the American Association ... cancer remains one of the most deadly; only 5 ... later. , Mark Pereira, Ph.D., senior author on the ...
(Date:2/9/2010)... infants born prematurely in the US, according to data ... These findings were reported at the 30th Annual Meeting ... also were published in the latest issue of the ... Researchers reported that CP is associated with inflammation of ... is more common in premature births from preterm labor ...
Breaking Medicine News(10 mins):Health News:Idaho House Moves State Closer to Health Care Disaster 2Health News:Idaho House Moves State Closer to Health Care Disaster 3Health News:Idaho House Moves State Closer to Health Care Disaster 4Health News:Exposure to secondhand smoke among children in England has declined since 1996 2Health News:Soft drinks may increase risk of pancreatic cancer 2Health News:Incidence of cerebral palsy on rise in US 2
... Nationwide,Health Properties, Inc. (NYSE: NHP ) announced ... share dividend on the company,s common stock,that will be ... on August,15, 2008., In addition, NHP,s Board of ... B cumulative convertible preferred stock that will,be paid on ...
... Not That! Authors Grade 43 National Chains; 6 Receive ... kids, menus are most likely to,make your children fat? ... differences among America,s favorite fast-food and sit-down,chain restaurants, according ... NOT,THAT! For Kids. Co-authors David Zinczenko and Matt Goulding ...
... Anpath Group, Inc.,(OTC Bulletin Board: ANPG), today announced that ... Gilroy have been appointed to its board of,directors and ... Mr. Boyer is the Chief Financial Officer of StrikeIron,Inc., ... Internet and Mr.,Gilroy is the founder and Managing Director ...
... 1 Conseco, Inc. (NYSE:,CNO) announced today that:, ... president of Conseco Insurance,Group (CIG), including Worksite Operations ... as executive vice president of operations,for Conseco, replaces ... reasons., -- Russell M. Bostick has been ...
... nutritional supplement no substitute for old-fashioned hard work, ... -- Taking creatine doesn,t improve exercise outcomes in ... a U.K. study reports. , Creatine is ... performance and muscle strength. This study included 100 ...
... that builds on healthcare reform proposal, WASHINGTON, ... today by Senators Max Baucus (D-MT) and Kent ... officer of the Blue,Cross and Blue Shield Association ... Senators Baucus and Conrad for introducing legislation that,would ...
Other Medicine News:Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3Health News:America's Worst Restaurants for Kids Revealed 2Health News:America's Worst Restaurants for Kids Revealed 3Health News:America's Worst Restaurants for Kids Revealed 4Health News:America's Worst Restaurants for Kids Revealed 5Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 2Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 3Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 4Health News:Stecher Named President of Conseco Insurance Group; Bostick to Lead Integrated IT and Operations Group at Conseco 2Health News:Creatine Has Negligible Effect on COPD Exercise Rehab 2Health News:BCBSA: Time Is Right for Comparative Effectiveness Research Institute 2
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
CritiCool™ offers precise cooling to the programmed target temperature by applying temperature control algorithm....
Medicine Products: